Cocrystal Pharma Announces $40 Million Bought Deal Offering Of Common Stock
Published
May 04 2021 at 10:41 PM GMT
Key
Points
Points
- BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.
- (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses.
Trending
Stats
- Published May 4, 2021 10:41 PM GMT